Drug Profile
PEK fusion protein vaccine
Alternative Names: PE-E7-K3Latest Information Update: 25 May 2016
Price :
$50
*
At a glance
- Originator Healthbanks Biotech Co
- Class Cancer vaccines; Protein vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cervical intraepithelial neoplasia
Most Recent Events
- 14 Jun 2013 HealthBanks Biotech completes enrolment in its phase I trial for Cervical intraepithelial neoplasia in USA (NCT01880411)
- 13 Jun 2013 Phase-I for Cervical intraepithelial neoplasia in USA (Parenteral)